Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Expert Opin Ther Pat. 2016;26(3):323–345. doi: 10.1517/13543776.2016.1154045

Figure 5.

Figure 5

Chemical structures of substituted phenylalanine-based inhibitors of FXIa (714) filed by Bayer Pharma. R is represented by one of the moieties listed from 7 through 14. Reported in brackets are the FXIa IC50 values (nM) and the concentrations required to double clotting time in APTT assay (μM).